Clinical trial
AMX0035 for Amyotrophic Lateral Sclerosis - Compassionate Use Protocol
NCT04516096 is registered in ClinicalTrials.gov with Amylyx Pharmaceuticals Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AMX0035 for Amyotrophic Lateral Sclerosis - Compassionate Use Protocol
- Lead sponsor
- Amylyx Pharmaceuticals Inc.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- November 22, 2020
- Completion date
- January 31, 2023
- Enrollment
- 28 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.